Literature DB >> 16130727

Chromatographic classification and comparison of commercially available reversed-phase liquid chromatographic columns containing polar embedded groups/amino endcappings using principal component analysis.

Melvin R Euerby1, Patrik Petersson.   

Abstract

Polar embedded phases have become increasingly popular in liquid chromatography (LC) analysis. These phases can produce diverse chromatographic selectivities as a result of their differing base silica, the type of polar embedded group (i.e. amide, urea, carbamate, ether or sulphonamide moieties) and the length of the alkyl ligand. Four column characterization protocols, using differing test probes, have been used to characterize 18 of these phases together with 17 alkyl phases (some of which contained novel polar endcapping, i.e. amino), which have been evaluated using principal component analysis (PCA). PCA provided graphical comparisons of the differences/similarities between these phases and between their corresponding C-alkyl, amino endcapped and enhanced polar selectivity phases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130727     DOI: 10.1016/j.chroma.2004.10.027

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

1.  Design of peptide standards with the same composition and minimal sequence variation to monitor performance/selectivity of reversed-phase matrices.

Authors:  Colin T Mant; Robert S Hodges
Journal:  J Chromatogr A       Date:  2012-01-25       Impact factor: 4.759

Review 2.  The importance of mass spectrometric dereplication in fungal secondary metabolite analysis.

Authors:  Kristian F Nielsen; Thomas O Larsen
Journal:  Front Microbiol       Date:  2015-02-17       Impact factor: 5.640

3.  Column Selection for Biomedical Analysis Supported by Column Classification Based on Four Test Parameters.

Authors:  Alina Plenis; Natalia Rekowska; Tomasz Bączek
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.